Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Barriers to using cost-effectiveness analysis in managed care decision making.

L A Prosser1, J P Koplan, P J Neumann

  • 1Department of Health Policy and Management, Harvard School of Public Health, Boston, MA 02115-5924, USA.

The American Journal of Managed Care
|September 8, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Automated symptom and treatment side effect monitoring for improved quality of life among adults with diabetic peripheral neuropathy in primary care: a pragmatic, cluster, randomized, controlled trial.

Diabetic medicine : a journal of the British Diabetic Association·2018
Same author

Determining the optimal strategy for the live-attenuated herpes zoster vaccine in adults.

Vaccine·2018
Same author

The Harvard-MIT-NEMC Research Training Program in Medical Informatics.

Yearbook of medical informatics·2016
Same author

Neoadjuvant therapy versus upfront surgical strategies in resectable pancreatic cancer: A Markov decision analysis.

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·2016
Same author

The Value of Risk-Stratified Information in the National Lung Cancer Screening Trial.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2016
Same author

Do Specialty Drugs Offer Greater Value for Money Than Traditional Drugs?

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2016

Managed care organizations (MCOs) could benefit from cost-effectiveness analysis (CEA) but face barriers. Overcoming these barriers is key to improving resource allocation and maximizing population health outcomes.

Area of Science:

  • Health economics
  • Health services research
  • Decision analysis

Background:

  • Managed care organizations (MCOs) are positioned to utilize cost-effectiveness analysis (CEA) for optimizing health outcomes within budget constraints.
  • Despite the potential, empirical evidence suggests limited integration of CEA into MCO decision-making processes.

Purpose of the Study:

  • To identify and analyze the barriers hindering the conduct and utilization of CEA within managed care settings.
  • To understand the factors impeding the adoption of CEA for resource allocation decisions in managed care.

Main Methods:

  • Qualitative analysis of existing literature and case studies on CEA implementation in managed care.
  • Identification of perceived and actual barriers through expert interviews and surveys (details not specified in abstract).

Related Experiment Videos

Main Results:

  • Key barriers include a lack of understanding regarding CEA's value and applicability.
  • Misaligned incentives, particularly a failure to adopt a lifetime perspective on health outcomes and costs, are significant obstacles.
  • Methodological limitations, whether real or perceived, also contribute to the underutilization of CEA.

Conclusions:

  • The underuse of CEA in managed care is driven by knowledge gaps and misaligned incentives, not solely by methodological issues.
  • Future research should focus on developing strategies to overcome these identified barriers.
  • Addressing these barriers can lead to improved resource allocation and enhanced health outcomes for populations covered by managed care organizations.